ArticleJCO precision oncology2024

Combination of MDM2 and Targeted Kinase Inhibitors Results in Prolonged Tumor Control in Lung Adenocarcinomas With Oncogenic Tyrosine Kinase Drivers and

Arielle Elkrief et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.